Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
50.17B | 50.62B | 48.62B | 43.77B | 34.52B | 26.48B | Gross Profit |
10.73B | 10.02B | 10.41B | 8.83B | 9.08B | 8.10B | EBITDA |
2.61B | 1.59B | 2.95B | 934.87M | 2.37B | 3.54B | Net Income |
1.28B | -435.33M | 1.00B | -1.55B | 431.07M | 2.14B |
Balance Sheet | Total Assets | ||||
36.30B | 37.58B | 36.09B | 36.90B | 31.78B | 28.97B | Cash, Cash Equivalents and Short-Term Investments |
4.01B | 3.44B | 3.19B | 3.68B | 4.15B | 8.28B | Total Debt |
16.36B | 16.59B | 15.68B | 16.30B | 14.31B | 13.56B | Total Liabilities |
26.36B | 27.30B | 26.28B | 28.19B | 22.05B | 19.64B | Stockholders Equity |
9.93B | 10.27B | 9.80B | 8.70B | 9.74B | 9.34B |
Cash Flow | Free Cash Flow | ||||
0.00 | 535.81M | 748.94M | -1.98B | 278.94M | 1.18B | Operating Cash Flow |
0.00 | 849.97M | 1.37B | -1.27B | 1.03B | 1.65B | Investing Cash Flow |
0.00 | -955.47M | -835.12M | -864.45M | -4.59B | -2.33B | Financing Cash Flow |
0.00 | 142.48M | -1.50B | 1.52B | -789.07M | 4.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥5.39B | 8.88 | 2.92% | 6.71% | 1.14% | ||
75 Outperform | ¥7.27B | 19.79 | ― | 14.66% | ― | ||
60 Neutral | ¥4.82B | 3.92 | -4.25% | 3.35% | 4.12% | -143.47% | |
56 Neutral | $3.05B | 4.98 | -5.68% | 6.43% | 7.96% | -51.05% | |
55 Neutral | ¥3.54B | 39.75 | ― | 2.25% | -12.69% | ||
51 Neutral | ¥4.63B | ― | 2.01% | -32.99% | -1509.56% | ||
31 Underperform | ¥5.56B | ― | ― | 2.37% | -83.58% |